Christophe de Romeuf

Person

Lambersart, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Chimeric protein in the treatment of amyloidosis
- Patent number 11,345,730
- Issue date May 31, 2022
- Centre National de la Recherche Scientifique (Cnrs)
- Christophe de Romeuf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD303 monoclonal antibodies
- Patent number 10,611,843
- Issue date Apr 7, 2020
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Nathalie Fournier
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies with enhanced ADCC function
- Patent number 9,718,889
- Issue date Aug 1, 2017
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Roland Beliard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of ADCC-optimized antibodies for treating weak patients
- Patent number 9,109,020
- Issue date Aug 18, 2015
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of ADCC-optimized antibodies for treating low-responder patients
- Patent number 7,713,524
- Issue date May 11, 2010
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of measuring activation of effector cells
- Patent number 7,595,165
- Issue date Sep 29, 2009
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Christophe de Romeuf
- G01 - MEASURING TESTING
Information Patent Grant
Anti-rhesus D monoclonal antibodies
- Patent number 7,541,029
- Issue date Jun 2, 2009
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Roland Beliard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CD303 MONOCLONAL ANTIBODIES
- Publication number 20180086834
- Publication date Mar 29, 2018
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Nathalie FOURNIER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSIS
- Publication number 20160264637
- Publication date Sep 15, 2016
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIO- TECHNOLOGIES
- Christophe DE ROMEUF
- G01 - MEASURING TESTING
Information Patent Application
MONOCLONAL ANTIBODIES WITH ENHANCED ADCC FUNCTION
- Publication number 20150152189
- Publication date Jun 4, 2015
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Roland Beliard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS
- Publication number 20140017243
- Publication date Jan 16, 2014
- Dominique Bourel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AN ANTIBODY DIRECTED AGAINST A MEMBRANE PROTEIN
- Publication number 20130315820
- Publication date Nov 28, 2013
- LFB BIOTECHNOLOGIES
- Nathalie Fournier
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel lgG3 Antibodies for Stimulating Phagocytosis
- Publication number 20070218052
- Publication date Sep 20, 2007
- Labopratoire Francais du Fractionnement et des Biotechnologies
- Christophe De Romeuf
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Anti-Rhesus D monoclonal antibodies
- Publication number 20070009522
- Publication date Jan 11, 2007
- LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Roland Beliard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christophe de Romeuf

Person

Patents Grantslast 30 patents

Chimeric protein in the treatment of amyloidosis

Anti-CD303 monoclonal antibodies

Monoclonal antibodies with enhanced ADCC function

Use of ADCC-optimized antibodies for treating weak patients

Use of ADCC-optimized antibodies for treating low-responder patients

Method of measuring activation of effector cells

Anti-rhesus D monoclonal antibodies

Patents Applicationslast 30 patents

ANTI-CD303 MONOCLONAL ANTIBODIES

CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSIS

MONOCLONAL ANTIBODIES WITH ENHANCED ADCC FUNCTION

USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS

USE OF AN ANTIBODY DIRECTED AGAINST A MEMBRANE PROTEIN

Novel lgG3 Antibodies for Stimulating Phagocytosis

Anti-Rhesus D monoclonal antibodies